Ignite Creation Date:
2024-05-06 @ 7:45 PM
Last Modification Date:
2024-10-26 @ 3:13 PM
Study NCT ID:
NCT06125197
Status:
RECRUITING
Last Update Posted:
2024-04-04
First Post:
2023-10-31
Brief Title:
Oncolytic Adenovirus TILT-123 With Pembrolizumab as Treatment for Refractory Non-Small Cell Lung Cancer
Sponsor:
Organization:
TILT Biotherapeutics Ltd